Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Ceccaldi
A Unique Subset of Epithelial Ovarian Cancers With Platinum Sensitivity and PARP Inhibitor Resistance
Cancer Research
Cancer Research
Oncology
Related publications
RING Domain–deficient BRCA1 Promotes PARP Inhibitor and Platinum Resistance
Journal of Clinical Investigation
Medicine
PARP Inhibitors in Ovarian Cancer: Sensitivity Prediction and Resistance Mechanisms
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
An Effective Epigenetic-Parp Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA-mutations
Clinical Cancer Research
Cancer Research
Oncology
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Current Problems in Cancer
Cancer Research
Oncology
PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated With PARP Inhibitor Resistance
Cell Reports
Biochemistry
Genetics
Molecular Biology
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2 -Mutated Carcinomas
Cell Reports
Biochemistry
Genetics
Molecular Biology
Reversion and Non-Reversion Mechanisms of Resistance to PARP Inhibitor or Platinum Chemotherapy in BRCA1/2-mutant Metastatic Breast Cancer
Layer‐by‐Layer Nanoparticles for Novel Delivery of Cisplatin and PARP Inhibitors for Platinum‐Based Drug Resistance Therapy in Ovarian Cancer
Bioengineering & Translational Medicine